In the first year following diagnosis, we found increased cumulative incidence risk ratios in a number of outcomes including: - Any mental, behavioural, or neurodevelopmental disorder 1.96 (1.93 - 1.99) - Postpartum depression 2.70 (2.61 - 2.79) - Eating disorders 2.06 (1.85 - 2.89) - PTSD 1.77 (1.69 - 1.86) We also saw significantly increased risk in rare but serious outcomes such as: - Wernicke's encephalopathy 2.39 (1.25 - 4.56) - Puerperal psychosis 1.80 (1.48 - 2.20) Interestingly, cases of hyperemesis gravidarum with metabolic disturbance displayed a significantly lower risk of any depression and postpartum depression compared with those without metabolic disturbance
Cureus 16(9):e69453
As noted in the podcast, this is not just for beauty but actually works at the surface and muscular levels while providing a relaxing scalp massage
of course, ascertainment is difficult if the characteristic clinical dyad of hemolytic anemia and metabolic acidosis is not recognized and urine organic acid studies are not obtained
Recommendations to Pharmacists Pharmacists should use a patient-centered approach and evaluate whether each individual patient would benefit from the addition of a GLP-1 RA as an alternative to thrice-daily prandial insulin injections
They suggest using a safe, stable dosage to minimise any risks and keep an eye on your health
